Shieldin and CST Co-orchestrate DNA Polymerase-dependent Tailed-end Joining Reactions Independently of 53BP1-governed Repair Pathway Choice

Overview

Journal bioRxiv

Date 2024 Jan 8

PMID 38187711

Authors

Ashleigh King

Pia Reichl

Jean S Metson

Robert Parker

Daniella Munro

Catarina Oliveira

Jordan R Becker

Daniel Biggs

Chris Preece

Benjamin Davies

J Ross Chapman

Affiliations

Soon will be listed here.

Abstract

53BP1 regulates DNA end-joining in lymphocytes, diversifying immune antigen receptors. This involves nucleosome-bound 53BP1 at DNA double-stranded breaks (DSBs) recruiting RIF1 and shieldin, a poorly understood DNA-binding complex. The 53BP1-RIF1-shieldin axis is pathological in -mutated cancers, blocking homologous recombination (HR) and driving illegitimate non-homologous end-joining (NHEJ). However, how this axis regulates DNA end-joining and HR suppression remains unresolved. We investigated shieldin and its interplay with CST, a complex recently implicated in 53BP1-dependent activities. Immunophenotypically, mice lacking shieldin or CST are equivalent, with class-switch recombination co-reliant on both complexes. ATM-dependent DNA damage signalling underpins this cooperation, inducing physical interactions between these complexes that reveal shieldin as a DSB-responsive CST adaptor. Furthermore, DNA polymerase ζ functions downstream of shieldin, establishing DNA fill-in synthesis as the physiological function of shieldin-CST. Lastly, 53BP1 suppresses HR and promotes NHEJ in BRCA1-deficient mice and cells independently of shieldin. These findings showcase the resilience of the 53BP1 pathway, achieved through the collaboration of chromatin-bound 53BP1 complexes and DNA end-processing effector proteins.

References

Xu G, Chapman J, Brandsma I, Yuan J, Mistrik M, Bouwman P . REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature. 2015; 521(7553):541-544. PMC: 4671316. DOI: 10.1038/nature14328. View

Groza T, Lopez Gomez F, Haseli Mashhadi H, Munoz-Fuentes V, Gunes O, Wilson R . The International Mouse Phenotyping Consortium: comprehensive knockout phenotyping underpinning the study of human disease. Nucleic Acids Res. 2022; 51(D1):D1038-D1045. PMC: 9825559. DOI: 10.1093/nar/gkac972. View

Wang X, Lee B, Zha S . The recent advances in non-homologous end-joining through the lens of lymphocyte development. DNA Repair (Amst). 2020; 94:102874. PMC: 7885906. DOI: 10.1016/j.dnarep.2020.102874. View

Ward I, Minn K, van Deursen J, Chen J . p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol. 2003; 23(7):2556-63. PMC: 150747. DOI: 10.1128/MCB.23.7.2556-2563.2003. View

Vincendeau E, Wei W, Zhang X, Planchais C, Yu W, Lenden-Hasse H . SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination. Nat Commun. 2022; 13(1):3707. PMC: 9240092. DOI: 10.1038/s41467-022-31287-3. View

Lord C, Ashworth A . Mechanisms of resistance to therapies targeting BRCA-mutant cancers. Nat Med. 2013; 19(11):1381-8. DOI: 10.1038/nm.3369. View

Setiaputra D, Escribano-Diaz C, Reinert J, Sadana P, Zong D, Callen E . RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1. Mol Cell. 2022; 82(7):1359-1371.e9. PMC: 8995355. DOI: 10.1016/j.molcel.2022.01.025. View

Barazas M, Annunziato S, Pettitt S, de Krijger I, Ghezraoui H, Roobol S . The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells. Cell Rep. 2018; 23(7):2107-2118. PMC: 5972230. DOI: 10.1016/j.celrep.2018.04.046. View

Noordermeer S, Adam S, Setiaputra D, Barazas M, Pettitt S, Ling A . The shieldin complex mediates 53BP1-dependent DNA repair. Nature. 2018; 560(7716):117-121. PMC: 6141009. DOI: 10.1038/s41586-018-0340-7. View

10.

Lange S, Wittschieben J, Wood R . DNA polymerase zeta is required for proliferation of normal mammalian cells. Nucleic Acids Res. 2012; 40(10):4473-82. PMC: 3378892. DOI: 10.1093/nar/gks054. View

11.

Findlay S, Heath J, Luo V, Malina A, Morin T, Coulombe Y . SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. EMBO J. 2018; 37(18). PMC: 6138439. DOI: 10.15252/embj.2018100158. View

12.

Fradet-Turcotte A, Canny M, Escribano-Diaz C, Orthwein A, Leung C, Huang H . 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature. 2013; 499(7456):50-4. PMC: 3955401. DOI: 10.1038/nature12318. View

13.

Becker J, Clifford G, Bonnet C, Groth A, Wilson M, Chapman J . BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination. Nature. 2021; 596(7872):433-437. DOI: 10.1038/s41586-021-03776-w. View

14.

Duarte A, Gogola E, Sachs N, Barazas M, Annunziato S, de Ruiter J . BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance. Nat Methods. 2017; 15(2):134-140. DOI: 10.1038/nmeth.4535. View

15.

Di Virgilio M, Callen E, Yamane A, Zhang W, Jankovic M, Gitlin A . Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science. 2013; 339(6120):711-5. PMC: 3815530. DOI: 10.1126/science.1230624. View

16.

Schimmel J, Munoz-Subirana N, Kool H, van Schendel R, Tijsterman M . Small tandem DNA duplications result from CST-guided Pol α-primase action at DNA break termini. Nat Commun. 2021; 12(1):4843. PMC: 8355091. DOI: 10.1038/s41467-021-25154-w. View

17.

Gu P, Min J, Wang Y, Huang C, Peng T, Chai W . CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J. 2012; 31(10):2309-21. PMC: 3364752. DOI: 10.1038/emboj.2012.96. View

18.

Mirman Z, Lottersberger F, Takai H, Kibe T, Gong Y, Takai K . 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in. Nature. 2018; 560(7716):112-116. PMC: 6072559. DOI: 10.1038/s41586-018-0324-7. View

19.

Ghezraoui H, Oliveira C, Becker J, Bilham K, Moralli D, Anzilotti C . 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ. Nature. 2018; 560(7716):122-127. PMC: 6989217. DOI: 10.1038/s41586-018-0362-1. View

20.

Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Velds A . Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A. 2007; 104(29):12111-6. PMC: 1924557. DOI: 10.1073/pnas.0702969104. View